NFKB1 and acute myeloid leukemia: Here, we demonstrated that NF-κB was significantly increased in patients with AML, in particular those with molecular abnormality (e.g., FLT-3 ITD), while a moderate increase was observed in patients with AML with normal cytogenetics in comparison to the control group.